P21

Overview

P21 is a nootropic peptide derived from ciliary neurotrophic factor (CNTF) that enhances neurogenesis and cognitive function. It contains an adamantane moiety that enables blood-brain barrier penetration. Research shows it increases BDNF expression, inhibits LIF signaling to promote neurogenesis, and reduces tau and amyloid pathology in Alzheimer’s disease models. Remarkably, P21 can boost neurogenesis in diseased brains above levels seen in healthy untreated brains.

Mechanism of action

P21 operates through multiple pathways: it inhibits leukemia inhibitory factor (LIF) signaling, removing a key roadblock to neurogenesis and shifting the brain toward a more embryologic state favoring neuron growth. It increases brain-derived neurotrophic factor (BDNF) expression and activates the BDNF/TrkB/PI3-K/AKT/GSK3β pathway. This pathway modulation improves cognitive function and reduces tau and amyloid pathologies.

Key research findings

• Potent promotion of neurogenesis in the dentate gyrus
• Increased BDNF expression
• Reduced tau protein pathology
• Reduced amyloid-beta plaque formation
• Improved cognitive function and memory
• Restored synaptic deficits in cortex and hippocampus
• Reduced mortality rate in AD models
• Crosses blood-brain barrier effectively

Research applications

Neurodegenerative Disease

• Alzheimer’s Disease — P021 markedly reduced tau pathology, attenuated Aβ generation, and rescued episodic memory impairment in 3xTg-AD mice.
• Neurodegeneration Prevention — Treatment during synaptic compensation period can prevent neurodegeneration and reduce mortality.
• Tau Pathology — Robust attenuation of tau pathologies through BDNF/TrkB/PI3-K/AKT/GSK3β pathway.

Cognitive Enhancement

• Neurogenesis — Enhances dentate gyrus neurogenesis so effectively it exceeds levels in healthy untreated brains.
• Memory Processes — Enhances memory processes through increased BDNF and restored synaptic function.
• Age-Related Cognitive Decline — May reduce natural decline in learning and memory in aged models by rescuing neurogenesis deficit.

Neuroprotection

• Synaptic Plasticity — Restores synaptic deficits in cortex and hippocampus.
• Neuronal Plasticity — Rescues deficits in neuronal plasticity.